Sleep Stability Intervention for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications, but it does exclude those using sleep medications or aids.
Is the Sleep Stability Intervention safe for humans?
How does the Sleep Stability Intervention treatment differ from other treatments for type 1 diabetes?
The Sleep Stability Intervention is unique because it focuses on improving sleep patterns to enhance glycemic control in people with type 1 diabetes, rather than directly targeting blood sugar levels with medication. This approach addresses sleep variability and duration, which are linked to better diabetes management and quality of life.678910
What data supports the effectiveness of the sleep stability intervention treatment for type 1 diabetes?
Research suggests that improving sleep can help manage type 1 diabetes better by potentially improving blood sugar control and reducing diabetes-related stress. Although specific data on the sleep stability intervention is limited, studies indicate that better sleep may lead to better diabetes management.167911
Are You a Good Fit for This Trial?
This trial is for individuals with type 1 diabetes who may be experiencing cardiovascular issues due to irregular or insufficient sleep. The study aims to understand how stabilizing sleep patterns can improve heart health and blood sugar control in these patients.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements of glycemic control, cardiovascular outcomes, and circadian regulation are taken
Treatment
Participants undergo a 4-week behavioral sleep stability intervention
Post-Intervention Assessment
Post-intervention measurements of glycemic control, cardiovascular outcomes, and circadian regulation are taken
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Sleep stability intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator